SOMA is proud to announce Spravato!

Ketamine has been studied for treatment of a variety of mental health conditions. It is thought to reset and re-establish connections within the brain to treat resistant depression and rapidly relieve suicidal thoughts.

We have partnered with Spravato to become an available treatment center here in Omaha! Please reach out to us to schedule and see about starting the process. Those patients who are already eligible or in the program can now choose us as a supported center.

Any specific questions please call us at: 531-267-0711

What is SPRAVATO® (esketamine) CIII nasal spray? SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: Adults with treatment-resistant depression (TRD)Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. This is a federally backed program that is covered by most insurance options. Please contact us for specific information regarding reimbursement and becoming eligible.


SPRAVATO® is the first prescription nasal spray, taken with an oral antidepressant, for:

  • Adults with treatment-resistant depressionXIn the SPRAVATO® clinical trials, treatment-resistant depression was diagnosed in adults who were struggling with major depressive disorder and had not responded adequately to at least two different antidepressants of adequate dose and duration in the current episode.
  • Depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions

Helpful Links: each of the articles below highlight the benefits of Spravato Treatments

Please contact us if you have any questions or check out our FAQ: